BASF: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market23 Nov 2010 • by Natalie Aster
New York - Detailed market research report “BASF: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market ” has been recently published by Venture Planning Group . The report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
The company owns the majority of its production sites, in Germany, Belgium, Denmark, Finland, France, Italy, The Netherlands, Spain, Turkey and the U.K. in Europe; Canada, Mexico and the U.S. in North America; Argentina, Brazil and Chile in South America; and China, India, Indonesia, Japan, Korea and Malaysia in the Asia, Pacific and Africa areas.
The group's main plant is based at Lugwigshafen, near Mannheim, south of Frankfurt.
Comprising some 2.5 square miles in area, BASF Lugwigshafen has the distinction of being the world's largest chemical plants. The main capital expenditure projects for the Performance Products segment currently include a new plant for acrylic monomers in Nanjing, China with a projected annual capacity at completion of 160,000 metric tons; and a new plant for cross-linked PVP-based products in Ludwigshafen, Germany.
Published: October 2010
Price: USD 1,500
Report Sample Abstract:
The company has been positioning itself as one of the leading chemical manufacturers in the Asian market. BASF has constructed state-of-the-art plants in the region to strengthen its position, secure its export position and support local plants. A joint venture with Sinopec opened a $2.9 billion petrochemical site in China. The company also started production at a new Verbund site with, Petronas in Malaysia, and began production on a site in Nanjing China. BASF has been expanding its activities in Japan through involvement in the restructuring of the Japanese chemical industry, and has been seeking appropriate acquisitions. The company acquired Takeda Kegaku Shiryo, a subsidiary of Takeda Chemical.
In Europe and North America, the company has been concentrating on businesses in which it holds competitive advantages over other chemical producers. The company is seeking to achieve long-term competitiveness through cost-effectiveness, and thus uses cost efficiency offered by integrated large-scale plants as well as technological progress in production processes. As part of the cost-containment effort, BASF closed 10 sites and 14 plants, including a 65,000 ton/year superabsorbents unit at Birkenhead, England that had been severely damaged by fire. BASF is planning to increase the proportion of its sales in cyclically sensitive and specialty products from about 50% to as much as 70%.
The company formed a subsidiary, BASF Future Business, in 2001, to develop new business areas in high-growth markets. In concert with BASF Venture Capital, the subsidiary is intended to provide the company with access to technologies and materials that complement BASF’s activities. BASF Future Business has a staff of ten who identify developing growth areas and analyze them for market size, customer base, necessary capital, suitable project partners, and status of the technology involved. BASF Venture Capital invests in start-ups that are developing new technologies that are either basic or likely to lead to innovative products.
Under its newest restructuring effort, BASF 2015, the company is concentrating on:
- Increased profit through concentrating on areas that management deems attractive and through cost reduction;
- Improved R&D and marketing worldwide, through collaborations with customers;
- Streamlined management;
- Sustainable development.
More information can be found in the report “BASF: Performance, Capabilities, Goals and Strategies in the Worldwide Life Science Intermediates Market ” by Venture Planning Group .
To order the report or ask for sample pages contact email@example.com